| 000 | 01637 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513193521.0 | ||
| 264 | 0 | _c19991227 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1701996 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHägglund, H | |
| 245 | 0 | 0 |
_aA prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cOct 1999 |
||
| 300 |
_a831-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFilgrastim |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xtherapy |
| 650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRingdén, O | |
| 700 | 1 | _aOman, S | |
| 700 | 1 | _aRemberger, M | |
| 700 | 1 | _aCarlens, S | |
| 700 | 1 | _aMattsson, J | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 24 _gno. 8 _gp. 831-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1701996 _zAvailable from publisher's website |
| 999 |
_c10473740 _d10473740 |
||